Approval · Notice of Compliance 3216 · 1998
MAVIK: Notice of Compliance 3216
Issued December 23, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3216
- Date
- December 23, 1998
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAVIK | 02239267 | Marketed |
Medicinal ingredients
- TRANDOLAPRIL 4 MG per CAP